Technical Note

Molecular Logic Gates on DNA Origami Nanostructures for MicroRNA Diagnostics

Laboratory of Physical Biology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China
National Engineering Research Center for Nanotechnology, Shanghai 200241, China
Anal. Chem., 2014, 86 (4), pp 1932–1936
DOI: 10.1021/ac403661z
Publication Date (Web): January 21, 2014
Copyright © 2014 American Chemical Society

Abstract

Abstract Image

Molecular computing holds great promise for diagnosis and treatment of diseases at the molecular level; nevertheless, designing molecular logic gates to operate programmably and autonomously for molecular diagnostics still remains challenging. We designed logic gates on DNA Origami for microRNA analysis. As a demonstration, two indicators of heart failure, microRNA-21 and microRNA-195, were selected as the logic inputs. The logic gates contain two main modules: computation module and output module, performing in a single DNA Origami nanostructure. The computation module recognizes disease indicators, while the output module display different nanoscale symbols, “+” (positive) or “–” (negative), depending on the computing results. We demonstrated that the molecular logic gates worked well with single and two input combinations.

Ten supporting figures, 6 DNA and microRNA sequences, and 226 DNA Origami sequences. This material is available free of charge via the Internet at http://pubs.acs.org.

Citation data is made available by participants in Crossref's Cited-by Linking service. For a more comprehensive list of citations to this article, users are encouraged to perform a search inSciFinder.

Explore by:

Metrics

Article Views: 2,213 Times
Received 12 November 2013
Date accepted 21 January 2014
Published online 21 January 2014
Published in print 18 February 2014
+
Altmetric Logo Icon More Article Metrics

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE